Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Research Report 2018

April 2018 | 103 pages | ID: P80AF33EEC1EN
QYResearch

Abstracts

The global Human cytomegalovirus 65 kDa Phosphoprotein market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Philippines plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.

This report studies the Human cytomegalovirus 65 kDa Phosphoprotein development status and future trend in Philippines, focuses on top players in Philippines, also splits Human cytomegalovirus 65 kDa Phosphoprotein by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.

The major players in Philippines market include

• Astellas Pharma Inc
• Hookipa Biotech AG
• Immunomic Therapeutics Inc
• Vakzine Projekt Management GmbH
• Vaximm AG
• VBI Vaccines Inc
• Vical Inc

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• HB-101
• CyMVectin
• ASP-0113
• PepVax
• Others

On the basis of the end users/Application, this report covers

• Brain Tumor
• Hemotaological Tumor
• Kidney Transplant Rejection
• Liver Transplant Rejection
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Research Report 2018

1 HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN OVERVIEW

1.1 Product Overview and Scope of Human cytomegalovirus 65 kDa Phosphoprotein
1.2 Classification of Human cytomegalovirus 65 kDa Phosphoprotein by Product Category
  1.2.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Comparison by Type (2013-2025)
  1.2.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Market Share by Type in 2017
  1.2.3 HB-101
  1.2.4 CyMVectin
  1.2.5 ASP-0113
  1.2.6 PepVax
  1.2.7 Others
1.3 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market by Application/End Users
  1.3.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Market Share Comparison by Application (2013-2025)
  1.3.2 Brain Tumor
  1.3.3 Hemotaological Tumor
  1.3.4 Kidney Transplant Rejection
  1.3.5 Liver Transplant Rejection
  1.3.6 Others
1.4 Philippines Revenue and Sales of Human cytomegalovirus 65 kDa Phosphoprotein (2013-2025)
  1.4.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2025)
  1.4.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate (%)(2013-2025)

2 PHILIPPINES HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN MARKET COMPETITION BY PLAYERS/MANUFACTURERS

2.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue and Share by Players/Manufacturers (2013-2018)
2.3 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Average Price (USD/Pcs) by Players/Manufacturers (2013-2018)
2.4 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Competitive Situation and Trends
  2.4.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Concentration Rate
  2.4.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Share of Top 3 and Top 5 Players/Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion in Philippines Market
2.5 Philippines Players/Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base Distribution, Sales Area, Product Type

3 PHILIPPINES HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN SALES AND REVENUE (VALUE) BY TYPE (2013-2018)

3.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Market Share by Type/ Product Category (2013-2018)
3.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Price (USD/Pcs) by Type (2013-2018)
3.4 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (%) by Type (2013-2018)

4 PHILIPPINES HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN SALES BY APPLICATION (2013-2018)

4.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Market Share by Application (2013-2018)
4.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities

5 PHILIPPINES HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN PLAYERS/SUPPLIERS PROFILES AND SALES DATA

5.1 Astellas Pharma Inc
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.1.2.1 Product A
    5.1.2.2 Product B
  5.1.3 Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.1.4 Main Business/Business Overview
5.2 Hookipa Biotech AG
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.2.2.1 Product A
    5.2.2.2 Product B
  5.2.3 Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.2.4 Main Business/Business Overview
5.3 Immunomic Therapeutics Inc
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.3.2.1 Product A
    5.3.2.2 Product B
  5.3.3 Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.3.4 Main Business/Business Overview
5.4 Vakzine Projekt Management GmbH
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.4.2.1 Product A
    5.4.2.2 Product B
  5.4.3 Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.4.4 Main Business/Business Overview
5.5 Vaximm AG
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.5.2.1 Product A
    5.5.2.2 Product B
  5.5.3 Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.5.4 Main Business/Business Overview
5.6 VBI Vaccines Inc
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.6.2.1 Product A
    5.6.2.2 Product B
  5.6.3 VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.6.4 Main Business/Business Overview
5.7 Vical Inc
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Human cytomegalovirus 65 kDa Phosphoprotein Product Category, Application and Specification
    5.7.2.1 Product A
    5.7.2.2 Product B
  5.7.3 Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  5.7.4 Main Business/Business Overview

6 HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN MANUFACTURING COST ANALYSIS

6.1 Human cytomegalovirus 65 kDa Phosphoprotein Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Human cytomegalovirus 65 kDa Phosphoprotein Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Human cytomegalovirus 65 kDa Phosphoprotein Major Manufacturers in 2017
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 PHILIPPINES HUMAN CYTOMEGALOVIRUS 65 KDA PHOSPHOPROTEIN MARKET SIZE (SALES AND REVENUE) FORECAST (2018-2025)

10.1 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD) Forecast (2018-2025)
10.2 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Forecast by Type (2018-2025)
10.3 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Philippines Market Size (Million USD) Status and Outlook (2013-2025)
Table Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Revenue (Million USD) Market Split by Product Type
Table Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) by Application (2017-2025)
Figure Product Picture of Human cytomegalovirus 65 kDa Phosphoprotein
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share by Type in 2017
Figure HB-101 Product Picture
Figure CyMVectin Product Picture
Figure ASP-0113 Product Picture
Figure PepVax Product Picture
Figure Others Product Picture
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Comparison by Application (2013-2025)
Figure Philippines Sales Market Share (%) of Human cytomegalovirus 65 kDa Phosphoprotein by Application in 2017
Figure Brain Tumor Examples
Figure Hemotaological Tumor Examples
Figure Kidney Transplant Rejection Examples
Figure Liver Transplant Rejection Examples
Figure Others Examples
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales of Key Players/Manufacturers (2013-2018)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (%) by Players/Manufacturers
Figure 2017 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (%) by Players/Manufacturers
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue by Players/Manufacturers (2013-2018)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share (%) by Players/Manufacturers
Figure 2017 Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue Share (%) by Players/Manufacturers
Table Philippines Market Human cytomegalovirus 65 kDa Phosphoprotein Average Price (USD/Pcs) of Key Players/Manufacturers (2013-2018)
Figure Philippines Market Human cytomegalovirus 65 kDa Phosphoprotein Average Price (USD/Pcs) of Key Players/Manufacturers in 2017
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Share of Top 3 Players/Manufacturers
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Market Share of Top 5 Players/Manufacturers
Table Philippines Players/Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Manufacturing Base Distribution and Sales Area
Table Philippines Players/Manufacturers Human cytomegalovirus 65 kDa Phosphoprotein Product Category
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) by Type (2013-2018)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (%) by Type (2013-2018)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Share (%) by Type (2013-2018)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) by Type in 2017
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Market Share by Type (2013-2018)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Type (2013-2018)
Figure Revenue Market Share of Human cytomegalovirus 65 kDa Phosphoprotein by Type in 2017
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Price (USD/Pcs) by Type (2013-2018)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (%) by Type (2013-2018)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) by Application (2013-2018)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) by Application (2013-2018)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) by Application (2013-2018)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) by Application in 2017
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (%) by Application (2013-2018)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Growth Rate (%) by Application (2013-2018)
Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure Astellas Pharma Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure Hookipa Biotech AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure Immunomic Therapeutics Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure Vakzine Projekt Management GmbH Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure Vaximm AG Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure VBI Vaccines Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Basic Information List
Table Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Sales Market Share (%) in Philippines (2013-2018)
Figure Vical Inc Human cytomegalovirus 65 kDa Phosphoprotein Revenue Market Share (%) in Philippines (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Human cytomegalovirus 65 kDa Phosphoprotein
Figure Manufacturing Process Analysis of Human cytomegalovirus 65 kDa Phosphoprotein
Figure Human cytomegalovirus 65 kDa Phosphoprotein Industrial Chain Analysis
Table Raw Materials Sources of Human cytomegalovirus 65 kDa Phosphoprotein Major Players/Manufacturers in 2017
Table Major Buyers of Human cytomegalovirus 65 kDa Phosphoprotein
Table Distributors/Traders List
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Price (USD/Pcs) Trend Forecast (2018-2025)
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Forecast by Type (2018-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Forecast by Type (2018-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share Forecast by Type in 2025
Table Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales (K Pcs) Forecast by Application (2018-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share Forecast by Application (2018-2025)
Figure Philippines Human cytomegalovirus 65 kDa Phosphoprotein Sales Volume Market Share Forecast by Application in 2025